Prof. Dr. med. Daniel Inderbitzin

Klinikleiter / Chefarzt Viszeralchirurgie soH

Tel. 032 627 45 51 E-Mail daniel.inderbitzin@spital.so.ch dbinderbitzin@gmx.ch

Titel

Prof. Dr. med.

Facharzt für Chirurgie

Mitglied FMH

Spezialitäten

Schwerpunkte

Viszeralchirurgie, Allgemeinchirurgie, Traumatologie

Roboter-assistierte Chirurgie

Education, Degrees, Certification

1984 Matura A, Kantonsschule Oerlikon, Zurich, Switzerland

1991 Medical Diploma; Faculty of Medicine, University of Zurich

1991 Dr. med. (MD Thesis); University of Zurich Morbus Hirschsprung. (MD Thesis 1988-1990): „Langzeitergebnisse der nach der Duhamel-Methode operierten Kinder.“

1994 Surgical Boards, Basic Examination

1997 Surgical Boards, Final Examination

1997 Laboratory Animal Science, Utrecht University, FELASA, Diploma Category C

1998 Specialist for General Surgery FMH

2004 Didactics for Medical Teaching

2006 Specialist for Visceral Surgery

2008 Venia docendi for Visceral Surgery, University of Bern

2012 Associate Professor for Visceral Surgery, University of Bern

2016 2017

Specialist for General Surgery and Traumatology Titular Professor for Visceral Surgery, University of Bern

2

Internships, Residencies

1991 - 1992 Intern in Surgery, Internal Medicine, Obstetrics and Gynecology, Regionalspital Praettigau, Schiers, Switzerland

1992 Military Service as MD in the Swiss Army

1992 - 1993 Resident in Surgery, Kantonales Spital Uznach, Switzerland

1993 - 1995 Resident in Surgery, Kreisspital Maennedorf, Switzerland

1995 - 1999 Resident in Surgery, Department of Surgery, University of Zurich Hospital, Zurich

Fellowships

1999 - 2001 Liver Support Research Laboratory, Cedars-Sinai Medical Center, Los Angeles, USA

2001 Stem Cell Group, Clinical Pharmacology and Toxicology, Department of Internal Medicine, University of Zurich Hospital, Zurich

2001 - 2002 Department of Surgery, Kantonsspital Aarau, Switzerland

Appointments

2002 Consultant Surgeon, Staff member, Department of Surgery, Kantonsspital Aarau, Switzerland

2002 Consultant Surgeon, Staff member, Research Coordinator, Department of Visceral and Transplantation Surgery, Bern University Hospital, Bern, Switzerland

2008 Senior Staff Surgeon, Department of Visceral and Transplantation Surgery, Bern University Hospital, Bern, Switzerland

2013 – 2016 Director and Chief Surgeon of the Surgical Clinics Tiefenau and Ziegler, Spital-Netz Bern AG, Bern, Switzerland

2016 - Director and Chief Surgeon of the Surgical Clinics soH (Solothurn Hospitals), Bürgerspital Solothurn, Kantonsspital Olten, Spital Dornach

Management Education

2006 Interdisciplinary post-diploma course: management in hospitals (13 days in 6 modules).

3

2007 - Continuous education in management skills. Action learning group, Piazza Consulting, Bern University Hospital (3 days per year)

2011 - 2012 Seminar for systemic management in health organisations. University of St. Gallen, Institute for systemic management and public governance (22 days in 6 modules).

2013 “Erfolgreiche Medienarbeit”, June 4th 2013

Visibility

2004 - 2010 Examinator for the surgery final exams (oral)

2005 - Coordinator for the surgery final exams (written and oral)

2006 - Member of the Bern University Hospital commission for blood transfusion

2007 - Member of the Bern University Hospital commission for pharmaceuticals

2007 - Faculty examinator of the medical exams commissions (written and oral exams) of the Bern University

2007 - Coordinator of the problem-based learning activities of the Department for Visceral and Transplantation Surgery

2007 - Coordinator of the clinical skills courses of the Department for Visceral and Transplantation Surgery

2007 - Coordinator of the student program including bed-side teaching of the Department for Visceral and Transplantation Surgery

2007 -2008 Project Leader: Reorganisation of the Medical Services in the new University Clinic of Visceral Surgery and Medicine (Fusion of Visceral Surgery, Gastroenterology, Hepatology 2008)

2009 Member of the Faculty Commission „Tumor Pathologie“

2009 - 2011 Swiss Representative in the Division of Transplantation of the UEMS, Section of Surgery

2010 - Examinator for the visceral surgery board exams (Schwerpunkttitel SGVC)

2010 - Member of the Scientific Committee of the Swiss Transplant Cohort Study, STCS.

2010 - 2013 Surgical member in the Transplant Board of the Bern University Hospital

4

2010 - 2013 Co-Organisator of the monthly interdisciplinary educational program in Visceral Surgery, Hepatology and Gastroenterology

2011 – 2016 2011 - 2016

Co-Organisator of the „Berner Symposium“ Stiftungsrat Insula-Stiftung zur Förderung der viszeralchirurgischen Forschung

2012 - 2013 Member of the faculty commission for gender equality

2013 Santé Media, Interview: “Neurogene Appendicopathie”

2014 - 2015 Member of the faculty commission „Kardiologie“

2014 - 2016 Certification “Darmzentrum Tiefenau” (DIN EN ISO 9001:2008)

2014 Member of the faculty commission “Umhabilitation”, October 2014

2015 2016 Membership in Professional Societies

Das ist der neue Chefarzt der soH-Chirurgie https://www.solothurnerzeitung.ch/solothurn/kanton-solothurn/das-ist-der-neue-chefarzt-der-soh-chirurgie-129697998 Amtlicher Anzeiger Nr. 27 vom 07.07.2016 “Steine im Bauch”

1991 Foederatio Medicorum Helveticorum (FMH)

2001 Schweizerische Gesellschaft für Chirurgie (SGC)

2002 Schweizerische Gesellschaft für Viszeralchirurgie (SGVC)

2011 Schweizerische Gesellschaft für Allgemeinchirurgie und Traumatologie (SGACT)

2014 Schweizerische Gesellschaft für Laparo- und Thorakoskopische Chirurgie (SALTC)

Reviewer Activities

2006 Journal of Hepatology, IF 2010: 9.334.

2006 American Journal of Transplantation, IF 2010: 6.051.

2007 Alimentary Pharmacology & Therapeutics, IF 2010 3.861.

5

2007 Digestive and Liver Disease, IF 2010: 2.805.

2008 Expert Review of Medical Devices, IF 2010: 2.043.

2008 Expert for the Swiss National Science Foundation

2009 BMC Gastroenterology, IF 2010: 2.468.

Collaborations

1997 - 1999 Collaboration with Dr. G. Vinci, Institut Pasteur, Paris. The role of C1-inhibitor in ischemia and reperfusion injury in transgenic, human C1-inhibitor overexpressing mice.

2000 Collaboration with Dr. Maurizio Muraca, Department of Medical and Surgical Sciences, University of Padua, Italy, and with R. Dal Toso, PhD, Istituto di Richerche Biotechniche, Vincentina, Italy. Entrapment of isolated rat hepatocytes by SiO2 Sol-Gel: A novel encapsulation technique.

2001 - 2007 Collaboration with Dr. Maurizio Muraca, Department of Medical and Surgical Sciences, University of Padua, Italy: Bone Marrow Derived Hepatocyte Stem Cells

2008 Collaboration with Prof. Dr.-Ing. S. Weber, Institute for Surgical Technology & Biomechanics, ARTORG-Center for Computer-assisted Surgery, University of Bern, Bern, Switzerland. Augmented reality in liver surgery.

2011 - Collaboration with Prof. A. Lugli, PD Dr. I. Zlobec, Department of Pathology, Bern University Hospital. Correlation of pathological parameters and clinical outcome in colorectal carcinoma

Grants

1999 - 2001 The mechanism of action of liver support systems in the setting of liver failure. Study grant by the Swiss National Science Foundation (SNF). CHF 100’000 (24 months).

2000 - 2004 Development of an extracorporal bioartificial liver device. Preclinical testing of a newly developed extracorporal bioartificial liver device in a large animal model of fulminant hepatic failure (Part E). Principal Investigator TANDEM project (SNF Nr. 3138-51172.97, Part E). CHF 100’000 (60 months).

2007 - 2008 Influence of Granulocyte-Colony Stimulating Factor (G-CSF) on the tumorigenicity of colorectal carcinoma. Novartis-Stiftung für die medizinisch-biologische Forschung (Nr. 07A08). CHF 41201 (12 months).

6

2007 - 2008 Influence of Granulocyte-Colony Stimulating Factor (G-CSF) on the tumorigenicity of colorectal carcinoma. Bernische Krebsliga. CHF 36060 (24 months)

2008 - 2009 Augmented Reality and Navigation for Liver Tumour Surgery I, SNF, NCCR, CO-ME. Co-Applicant. CHF 127’000 (12 months).

2008 - 2010 The epithelial mesenchymal transition in the evolution and progression of cholangiocarcinoma: role of alpha V beta 6 integrin as an antitumor target.

2009 - 2010 Augmented reality and navigation for liver tumor surgery II. SNF, NCCR, CO-ME. Clinical partner. CHF 85’000 (12 months).

2011 - 2012 High Precision Liver Surgery. Commission for Technology and Innovation (KTI). Co-Applicant. CHF 330’000 (24 months).

2011 - 2013 Liver Navigation and Planning. Eurostars/ Eureka. Co-Applicant. CHF 700’000 (36 months).

2014 - 2016 Assessment of intratumoral budding in preoperative biopsies of colon and rectal cancer patients. Study Grant University Hospital Bern. CHF 95’500 (24 months).

Original Articles 1. Clinical relevance of Hirschsprung-associated neuronal intestinal dysplasia (HANID

B. Hanimann, D. Inderbitzin, J. Briner, P. Sacher. Eur J Pediatr Surg 1992; 2 (3): 147-149. (IF 2010: 0.621)

2. Der Bedarf an Bluttransfusionen bei elektiven Koloneingriffen - Ist die praeoperative

Eigenblutspende sinnvoll? (The need for blood transfusions in elective colon surgery - is preoperative autotransfusion useful?) R. Spalinger, D. Inderbitzin, A. Hollinger.

Swiss Surgery 1996; 2 (5): 208-211. Is growth influencing diameter and function of laparoscopic TESA hepatico-jejunostomy? A comparison of adult minipigs and juvenile domestic swine. D. Inderbitzin, R. Schmid, F. Hetzer, K. Zucker, O. Schoeb. J Invest Surg 1998; 11 (2): 115-122. (IF 2010: 0.950)

3. Is growth influencing diameter and function oflaparoscopic TESA hepatico-

jejunostomy? A comparison of adult minipigs and juvenile domestic swine. D. Inderbitzin, R. Schmid, F. Hetzer, K. Zucker, O.Schoeb. J Invest Surg 1998; 11 (2): 115-122(IF 2010: 0.950)

4. Laparoscopic sigmoid resection: a comparative experimental study between double-

stapling and foreign material free biostent-technique (TESA). F. Hetzer, R. Schmid, D. Inderbitzin, O. Schoeb. J Laparoendosc Adv A 1998; 8 (5):285-293. (IF 2010: 1.198)

7

5. Chirurgische Schmerztherapie beim inoperablen metastasierenden Oberbauchtumor durch bilaterale thorakoskopische Splanchnikektomie. (Surgical pain therapy in inoperable metastatic epigastric tumor by bilateral thoracoscopic splanchnicectomy.) D. Inderbitzin, R. Schmid, O. Schoeb, W. Weder. Schweiz Med Wochenschr 1998; 128 (38): 1408-1413.

6. Primary small bowel carcinoma: a case report.

D. Inderbitzin, M. Weber, G. Cathomas, F. Largiader. Swiss Surgery 2000; 6: 182-183.

7. Inhibition of signaling transducer and activator of transcription factor 3 in rats with

acute hepatic failure. Y. Kamohara, N. Sugiyama, T. Mizuguchi, D. Inderbitzin, H. Lilja, Y. Middleton, T. Neuman, A. A. Demetriou, J. Rozga. Biochem Bioph Res Co 2000; 273: 129-35. (IF 2010: 2.595)

8. Optimized veno-venous bypass with the affinity pump.

C. Jaggy, M. Lachat, D. Inderbitzin, B. Leskosek, D. Candinas, T. Burkhard, M. Turina. ASAIO J 2001; 47: 56-59. (IF 2010: 1.221)

9. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte

stem cells. I. Avital, D. Inderbitzin, T. Aoki, D. Tyan, A. Cohen, C. Ferraresso, J. Rozga, W. Arnaout, A. Demetriou. Biochem Bioph Res Co 2001; 288: 156-164. (IF 2010: 2.595)

10. Glycerol suppresses proliferation of rat hepatocytes and human HepG2 cells.

N. Sugiyama, T. Mizuguchi, T. Aoki, T. Hui, D. Inderbitzin, A. Demetriou, J.Rozga. J Surg Res 2002; 103: 236-42. (IF 2010: 2.239)

11. Increased susceptibility of the left compared to the right ventricle to remote

ischemia/reperfusion injury in human C1-inhibitor-overexpressing transgene mice. J. Grunenfelder, D. Inderbitzin, G. Zund, I. Avital, T. Burkhardt, D. Candinas, M. Turina. J Invest Surg 2002 Sep-Oct;15(5):281-6. (IF 2010: 0.950)

12. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.

T. Aoki, Y. Umehara, C. Ferraresso, N. Sugiyama, Y. Middleton, I. Avital, D. Inderbitzin, A. Demetriou, J. Rozga. Cell Transplant 2002;11(6):553-61. (IF 2010: 6.204)

13. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective

randomized controlled trial. P. Carcoforo, G. Soliani, U. Maestroni, A. Donini, D. Inderbitzin, T. Hui, A. Lefor, I. Avital, G. Navarra. J Am Coll Surgeons 2003 Mar;196(3):365-9. (IF 2010: 4.241)

14. Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing

human C1 inhibitor. D. Inderbitzin, G. Beldi, I. Avital, G. Vinci, D. Candinas, Eur Surg Res 2004; 36:142-7. (IF 2010: 1.214)

15. Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver

development and heavy metal detoxification in the adult liver.

8

Y. Wang, P. Lichtlen, U. Wimmer, D. Inderbitzin, B. Stieger, P. Meier, L. Hunziker, T. Stallmach, R. Forrer, T. Rülicke, O. Georgiev, W. Schaffner. Faseb J 2004; 18(10): 1071-9. (IF 2010: 6.515)

16. Small hepatocytes in culture develop polarized transporter expression and

differentiation. M.-A. Sidler Pfändler, M. Höchli, D. Inderbitzin, P. Meier, B. Stieger. J Cell Sci 2004; 117: 4077-87. (IF 2010: 6.290)

17. Magnetic resonance imaging provides accurate and precise volume determination of

the regenerating mouse liver. D. Inderbitzin, M. Gass, G. Beldi, E. Ayouni, A. Nordin, D. Sidler, B. Gloor, D. Candinas, C. Stoupis. J Gastroinest Surg 2004; 8(7): 806-11. (IF 2010: 2.733)

18. Interleukin-3 Induces hepatocyte specific metabolic activity in bone marrow derived

liver stem cells. D. Inderbitzin, I. Avital, A. Keogh, G. Beldi, M. Quarta, B. Gloor, D. Candinas. J Gastroinest Surg 2005; 9(1): 69-74. (IF 2010: 2.733)

19. Molecular absorbent recirculating system for the treatment of acute liver failure after

major liver resections and before and after orthotopic liver transplantation. D. Inderbitzin, B. Muggli, A. Ringger, G. Beldi, M. Gass, B. Gloor, D. Uelinger, B. Regli, J. Reichen, D. Candinas. J Gastroinest Surg 2005; 9(8): 1155-62.(IF 2010: 2.733)

20. Functional comparison of rat bone marrow derived liver stem cells: selection strategy

for cell based therapy. D. Inderbitzin, I. Avital, B. Gloor, A. Keogh, D. Candinas. J Gastroinest Surg 2005; 9(9): 1340-5. (IF 2010: 2.7.33)

21. Kidney transplantation improves survival and is indicated in Fabry’s disease.

D. Inderbitzin, I. Avital, F. Largiadèr, B. Vogt, D. Candinas. Transplantation Proceedings 2005; 37: 4211-4. (IF 2010: 0.993)

22. Intraoperative three-dimensional fluoroscopic cholangiography.

G. Beldi, M. Styner, S. Schindera, D. Inderbitzin, D. Candinas Hepato-Gastroenterology 2006; 53: 157-9. (IF 2010: 0.677)

23. Interferon-inducible expression of APOBEC3B editing enzymes in human

hepatocytes and inhibition of hepatitis B virus replication. M. Bonvin, F. Achermann, I. Greeve, D. Stroka, A. Keogh, D. Inderbitzin, D. Candinas, P. Sommer, S. Wain-Hobson, J.-P. Vartanian, J. Greeve. Hepatology 2006; 43: 1364-74 (IF 2010: 10.885)

24. Analysis of stapling versus endoloops in appendiceal stump closure.

G. Beldi, S. Vorburger, L. Bruegger, T. Kocher, D. Inderbitzin, D. Candinas British Journal of Surgery 2006; 93: 1390-3 (IF 2010: 4.444)

25. Regenerative capacity of individual liver lobes in the microsurgical mouse model.

D. Inderbitzin, P. Studer, D. Sidler, G. Beldi, B. Gloor, V. Djonov, A. Keogh, D. Candinas. Microsurgery 2006; 26 (6): 465-9. (IF 2010: 1.555)

26. Multicenter study on peri- and ostoperative central venous oxygen saturation in high-

risk surgical patients.

9

Collaborative study group on perioperative ScvO2 monitoring: H. Bracht, V. Eigenmann, M. Haenggi, D. Inderbitzin, S. M. Jakob, S. Loher, C. Raeber, J. Takkala, A. Vogt, K. Mäkinen, P. Miettinen, M. Niskanen, I. Parviainen, H. Leppikangas, S. Nunes, E. Ruokonen. Crit Care 2006; 10 (6): R158 (IF 2010: 4.595)

27. The in vitro effect of interleukin-3 and interleukin-6 on the hepatocyte specific metabolic

capacity of adult bone marrow derived liver stem cells. D. Inderbitzin, D. Sidler, I. Avital, D. Candinas. Online (December 12th 2006): Journal of Organ Dysfunction 2006

28. Stent grafting of acute hepatic artery bleeding following pancreatic head resection C. Stoupis, K. Ludwig, D. Inderbitzin, D. D. Do, J. Triller. Eur Radiol 2007; 17(2):401-8 (IF 2010: 3.594)

29. Granulocyte colony-stimulating factor supports liver regeneration in a small-for-size

liver remnant mouse model. D. Inderbitzin, G. Beldi, D. Sidler, P. Studer, A. Keogh, S. Bisch-Knaden, R. Weimann, A. Kappeler, B. Gloor, D. Candinas. J Gastrointest Surg 2007; 11(3):280-5 (IF 2010: 2.733)

30. Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation. Y. Banz, D. Inderbitzin, C. A. Seiler, S. W. Schmid, J.-F. Dufour, A. Zimmermann, P. Mohacsi, D. Candinas. Transplant International 2007; 20(8):722-7 (IF 2010: 3.211)

31. Bone marrow derived beta-2-microglobulin-/Thy-1-+ cells differentiate into hepatocytes

following intraportal infusion after reversible hepatic ischemia/reperfusion injury and improve the metabolic disorder in the gunn rat. M. Muraca, C. Ferraresso, M. Vilei, A. Granato, E. Cozzi, M. Rugge, K. Pauwelyn, I. Avital I, D. Inderbitzin, A. Demetriou, G. Realdi. Gut 2007; 56(12):1725-35 (IF 2010: 10.614)

32. Abdominal magnetic resonance imaging in small rodents using a clinical 1.5 tesla MR scanner. D. Inderbitzin, C. Stoupis, D. Sidler, M. Gass, D. Candinas. Methods 2007; 43(1):46-53 (IF 2010: 4.527)

33. Indocyanin-green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. L. Brügger, P. Studer, S. Schmid, G. Pestel, J. Reichen, C. Seiler, D. Candinas, D. Inderbitzin J Gastrointest Surg 2008; 12(1):67-72 (IF 2010: 2.733)

34. Nutrition and liver transplantation.

F. Stickel, D. Inderbitzin, D. Candinas Nutr Rev 2008; 66(1):47-54 (IF 2010: 4.077)

35. Granulocyte-colony stimulating factor increases hepatic sinusoidal perfusion during liver regeneration in mice. D. Sidler, P. Studer, S. Küpper, B. Gloor, D. Candinas, J. Haier, D. Inderbitzin J Invest Surg 2008; 21(2):57-64 (IF 2010: 0.950)

36. Acute lower gastrointestinal hemorrhage: minimally invasive management with microkatheter embolisation.

10

R. Kickuth, H. Rattunde, J. Gschossmann, D. Inderbitzin, K. Ludwig, J. Triller J Vasc Interv Radiol 2008; 19(9): 1289-96 (IF 2010: 2.064)

37. Multiparameter flow cytometric characterization of MHC class I negative bone marrow

cells. M. Quarta, D. Stroka, A. Keogh, D. Sidler, I. Avital, B. Gloor, M. Muraca, D. Candinas, D. Inderbitzin Med Sci Monit 2008; 14(12): BR286-93 (IF 2010: 1.699)

38. Concomitant injuries are an important determinant of outcome of high-grade blunt

hepatic trauma. B. Schüriger, D. Inderbitzin, M. Schäfer, R. Kickuth, A. Exadaktylos, D. Candinas BJS 2009; 96(1):104-10 (IF 2010: 4.444)

39. Validation of the estimation of physiological ability and surgical stress (E-PASS) score

for liver surgery. V. Banz, P. Studer, D. Inderbitzin, D. Candinas World J Surg 2009; 33(6): 1259-65 (IF 2010: 2.693)

40. The accuracy of FAST in relation to grade of solid organ injuries: A retrospective

analysis of 226 trauma patients with liver or splenic lesion. B. Schnüriger, J. Kilz, D. Inderbitzin, M. Schafer, R. Kickuth, M. Luginbühl, D. Candinas, A. Exadaktylos, H. Zimmermann. BMC Medical Imaging 2009; 9(1): 3

41. Long-term quality of life after hepatic resection: Health is not simply the absence of

disease. V. Banz, D. Inderbitzin, R. Fankhauser, P. Studer, D. Candinas World J Surg 2009; 33(7): 1473-80 (IF 2010: 2.693)

42. Surgery-related risk factors.

P. Studer, D. Inderbitzin Curr Opin Crit Care 2009, 15(4):328-32 (IF 2010: 2.551)

43. Automatic algorithm for monitoring systolic pressure variation (SPV) and difference in

pulse pressure. G. Pestel, K. Fukui, V. Hartwich, P. Schumacher, A. Vogt, L. Hiltebrand, A. Kurz, Y. Fujita, D. Inderbitzin, D. Leibundgut Anesth Analg 2009; 108(6): 1823-9 (IF 2010: 3.274)

44. Evaluation of physical and mental recovery status after elective liver resection.

M. Arnberger, A. Vogt, P. Studer, D. Inderbitzin, C. Pulver, B. Röhrig, S. Jakob, R. Greif Eur J Anaesthesiol 2009; 26(7): 559-65 (IF 2010: 1.679)

45. Peri-operative adrenocortical response to low-dose (1 microg) ACTH and relation to

postoperative complications in patients undergoing elective abdominal surgery. L. Brander, T. Haltmeier, A. Suter, P. Studer, D. Inderbitzin, D. Candinas, A. Vogt, C. Henzen, J. Takala, S. Jakob Surgery 2009; 146 (1): 88-99 (IF 2010: 3.406)

46. Fulminant liver failure after vancomycin in a sulfasalazine induced DRESS syndrome;

fatal recurrence after liver transplantation. M. Mennicke, A. Zawodniak, M. Keller, L. Wilkens, N. Yawalkar, F. Stickel, A. Keogh, D. Inderbitzin, D. Candinas, W.J. Pichler Am J Transplant 2009; 9(9):2197-202 (IF 2010: 6.048)

11

47. Improving outcome after major surgery: Pathophysiological considerations.

V. Banz, S. Jakob, D. Inderbitzin Anesth Analg 2011;112(5):1147-55 (IF 2010: 3.274)

48. Management of blunt injuries to the spleen.

P. Renzulli, T. Gross, B. Schnüriger, A. Schöpfer, D. Inderbitzin, A. Exadaktylos, H. Hoppe, D. Candinas Br J Surg 2010; 97(11):1696-703 (IF 2010: 4.444)

49. Colon cancer cells produce immunoregulatory glucocorticoids. D. Sidler, P. Renzulli, C. Schnoz, B. Berger, S. Schneider-Jakob, C. Flück, D. Inderbitzin, N. Corazza, D. Candinas, T. Brunner Oncogene 2011; 30(21):2411-19 (IF 2010: 7.414)

50. A navigation system for open liver surgery: Design, workflow, and first clinical applications M. Peterhans, A. vom Berg, B. Dagon, D. Inderbitzin, C. Baur, D. Candinas, S. Weber Int J Med Robot 2011; 7(1):7-16 (IF 2010: 1.257)

51. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly

differentiated hepato- and cholangiocellular carcinoma. L. Wilkens, R. Jaggi, C. Hammer, D. Inderbitzin, O. Giger, N. von Neuhoff Virchows Archive 2011; 458(6):697-708 (IF 2010: 2.336)

52. Estimation of physiologic ability and surgical stress (E-PASS) score does not predict

immediate out come after pancreatic surgery. S. Deyle, V. Banz, D. Inderbitzin, M. Wagner, D. Candinas, B. Gloor Pancreas 2011; 40(5):723-29 (IF 2010: 2.607)

53. Low-dose recombinant factor VIIa for massive bleeding: A single centre observational

cohort study with 73 patients. P. Schmid, A. Mordasini, M. Luginbühl, B. Regli, H. P. Kohler, H. Zimmermann, D. Inderbitzin, A. Hirt, B. Lämmle, L. Alberio Swiss Medical Weekly 2011; 141: w13213 (IF 2010: 1.823)

54. Colon cancer cells produce immunoregulatory glucocorticoids.

D. Sidler, P. Renzulli, C. Schnoz, B. Berger, S. Schneider-Jakob, C. Flück, D. Inderbitzin, N. Corazza, D. Candinas, T. Brunner Oncoimmunology 2012; 1;1 (): 529-530 (IF 2010: 6.283)

55. How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic

cancer? E. Angst, C. Kim-Fuchs, Y. Chittazhathu Kurian Kuruvilla, D. Inderbitzin, M. Montani, D. Candinas, B. Gloor. J Gastrointest Surg 2012; 16(3):673. (IF 2010: 2.733)

56. Role of intra- and peritumoral budding in the interdisciplinary management of rectal

cancer patients. I. Zlobec, M. Borner, A. Lugli, D. Inderbitzin. Int J Surg Oncol 2012; 2012:795945.

57. Incision length for kidney transplantation does not influence short- or long-term outcome: a prospective randomized controlled trial. T. Malinka, V. M. Banz, J. Wagner, D. Candinas, D. Inderbitzin. Clin Transplant. 2013; 27(5):E538-45.

12

58. Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer. H. Dawson, V. H. Koelzer , A. C. Lukesch, M. Mallaev, D. Inderbitzin, A. Lugli, I. Zlobec. Front Oncol. 2013; 11;3:265.

59. Introduction of a new policy of no nighttime appendectomies: impact on appendiceal

perforation rates and postoperative morbidity. Schnüriger B, Laue J, Kröll D, Inderbitzin D, Seiler CA, Candinas D. World J Surg. 2014;38(1):18-24.

60. Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph

node and distant metastases in colon and rectal cancer patients. Zlobec I, Hädrich M, Dawson H, Koelzer VH, Borner M, Mallaev M, Schnüriger B, Inderbitzin D, Lugli A. Br J Cancer. 2014; 18;110(4):1008-13.

61. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts

nodal metastasis and survival. Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D. J Transl Med. 2014; 29;12:81.

62. Laparoscopic versus open end colostomy closure: a single-center experience.

Studer P, Schnüriger B, Umer M, Kröll D, Inderbitzin D, Candinas D. Am Surg. 2014;80(4):361-5.

63. Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19

as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients. Helbling M, Lukesch A, Haimovici A, Karamitopoulou E, Berger MD, Hädrich M, Mallaev M, Schnüriger B, Koelzer VH, Dawson H, Borner M, Langer R, Rosenberg R, Nitsche U, Inderbitzin D, Lugli A, Tschan M, Zlobec I. Oncotarget. 2014; 15;5(13):4671-82.

64. Computer planned, image-guided combined resection and ablation for bilobar

colorectal liver metastases. Banz VM, Baechtold M, Weber S, Peterhans M, Inderbitzin D, Candinas D. World J Gastroenterol. 2014; 28;20(40):14992-6.

65. Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis

resistance as a survival mechanism of tumour budding cells. Dawson H, Grundmann S, Koelzer VH, Galván JA, Kirsch R, Karamitopoulou E, Lugli A, Inderbitzin D, Zlobec I. Histopathology. 2015; 66(5): 715-25.

66. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma

influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer. Galván JA, Helbling M, Koelzer VH, Tschan MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H, Inderbitzin D, Lugli A, Zlobec I. Oncotarget. 2015 Jan 20;6(2):874-85.

67. Tumor budding in colorectal cancer revisited: results of a multicenter interobserver

study. Koelzer VH, Zlobec I, Berger MD, Cathomas G, Dawson H, Dirschmid K, Hädrich M,

13

Inderbitzin D, Offner F, Puppa G, Seelentag W, Schnüriger B, Tornillo L, Lugli A. Virchows Arch. 2015 May;466(5):485-93.

68. VE immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer. Schafroth C, Galván JA, Centeno I, Koelzer VH, Dawson HE, Sokol L, Rieger G, Berger MD, Hädrich M, Rosenberg R, Nitsche U, Schnüriger B, Langer R, Inderbitzin D, Lugli A, Zlobec I. Oncotarget. 2015 Dec 8;6 (39): 41453-63.

69. Intraoperative image-guided navigation system: development and applicability in 65 patients undergoing liver surgery. Banz VM, Müller PC, Tinguely P. Inderbitzin D, Ribes D, Peterhans M, Candinas D, Weber S. Langenbecks Arch Surg. 2016 Jun;401(4):495-502.

70. Superselective transcatheter arterial transcatheter arterial embolization in patients with acute peripancreatic bleeding complications: review of 44 cases. Kickuth R, Hoppe H, Saar B, Inderbitzin D, Triller J, Raessler S, Gschossmann J. Abdom Radiol (NY). 2016 Sep;41(9):1782-92.

71. Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT. Schawkat K, Kühn W, Inderbitzin D, Gloor B, Heverhagen JT, Runge VM, Christe A. PLoS One. 2016 Nov 28;11(11):e0166003.

72. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer. Rieger G, Koelzer VH, Dawson HE, Berger MD, Hädrich M, Inderbitzin D, Lugli A, Zlobec I. Histopathology. 2017 Jun;70(7):1044-1051.

73. Digital analysis and epigenetic regulation of the signature of rejection in colorectal

cancer. Koelzer VH, Sokol L, Zahnd S, Christe L, Dawson H, Berger MD, Inderbitzin D, Zlobec I, Lugli A. Oncoimmunology. 2017 Feb 6;6(4):e1288330. doi: 10.1080/2162402X.2017.1288330. eCollection 2017.

74. CDX2 is an independent prognostic factor and regulated by promoter methylation and

histone deacetylation in colorectal cancer Graule J, Uth K, Fischer E, Centeno I, Galvan J.A., Eichmann M, Rau T, Langer R, Dawson H, Nitsche U, Träger P, Berger M, Schnüriger B, Hädrich M, Studer P, Inderbitzin D, Lugli A, Tschan M, Zlobec I CCR-17-2820

75. Robotic Intracorporal Anastomosis in Diverticular Disease

76. Computed tomography imaging for the characterisation of drugs with radiation density

measurements and HU spectroscopy Sieron D, Steib M, Suter D, Obmann V, Huber A, Ebner L, Inderbitzin D, Christe A Swiss Medical Weekly – 14585

77. SMW-D17-00242R1 Computed Tomography Imaging for the Characterization of Drugs using Radiation Density Measurements and HU-Spectroscopy

14

78. CLEP-D-18-00005 CDX2 is an independent prognostic factor and regulated by promoter methylation and histone de-acetylation in colorectal cancer Graule J; Uth K; Fischer E; Centeno Ramos I; Galván J A; Eichmann M; Rau T; Langer R; Dawson H; Nitsche U; Traeger P; Berger M D; Schnüriger B; Bionda M; Studer P; Inderbitzin D; Lugli A; Tschan M; Inti Zlobec Clinical Epigenetics

Book Chapters, Newsletters, Letters to the Editor 1. Hepatocyte Transplantation.

D. Inderbitzin, J. Rozga, A. A. Demetriou. Surgical Research. First edition. Edited by W. W. Souba and D. W. Wilmore, Academic Press, San Diego, California.

2. School of Hepatology (2003)

Gutartige Lebertumore D. Inderbitzin, D. Candinas, http://www.ikp.unibe.ch/lab2/soh/index.htm

3. Functional comparison of isolation and culture methods for the purification of adult liver

stem cells from bone marrow. D. Inderbitzin, A. Keogh, G. Beldi, M. Gass, D. Stroka, B. Gloor, B. Stieger, D. Candinas. International Proceedings. 2003: 135-9.

4. Ischemia and reperfusion injury is mitigated in transgenic C-1-Inhibitor over-expressing

mice. D. Inderbitzin, G. Beldi, I. Avital, G. Vinci, D. Stroka, D. Candinas. International Proceedings. 2003: 129-33.

5. Weiterentwicklung der Leberchirurgie durch Aktivierung von adulten Leber-

Stammzellen. D. Inderbitzin, D. Candinas. Unipress 120. 2004: 11-13. http://publicrelations.unibe.ch/unipress/heft120/beitrag3.html

6. Leberregeneration mit Stammzellaktivierung.

D. Inderbitzin, D. Sidler, G. Beldi, P. Studer, D. Candinas Bioworld 03-2004: 2-3.

7. The effect of granulocyte-colony stimulating factor on liver regeneration.

D. Inderbitzin Newletter DKF 09/05 www.dkf.unibe.ch

8. Hepatobiliäre Chirurgie bei malignen Erkrankungen der Leber: Ein Repetitorium für

Facharztanwärter FMH Chirurgie. D. Inderbitzin, C. A. Seiler, D. Candinas Chirurgische Facharztvorbereitung: Modul I, März 2006, Basel; Neuauflage I, März 2008.

9. Viszeralchirurgie: Fortschritte in der Behandlung von Pankreaserkrankungen und

kolorektalen Metastasen. B. Gloor, D. Inderbitzin, D. Candinas Schweiz Med Forum 2007: 38-40.

15

10. Strengthening Cooperation and Enhancing Activation in Problem-Based Learning

through Concrete External Representations. M. Künzel, D. Inderbitzin Tübinger Beiträge zur Hochschuldidaktik 2008. http://tobias-lib.ub.uni-tuebingen.de/volltexte/2008/3331/

11. Akuter Bauchschmerz: An was denkt der Chirurg?

Y. Borbély, D. Inderbitzin, D. Candinas The Medical Journal 2009, 1: 16-19.

12. A porcine liver model for validation of registration accuracy in image-guided surgery.

M. Peterhans, B. Dagon, A. Vom Berg, D. Inderbitzin, C. Baur, S. Weber Informatik aktuell, Bildverarbeitung für die Medizin 2009, Part 15, 361-365.

13. Der unklare Leberrundherd

V. Banz, D. Inderbitzin, Y. Banz, C. Seiler, D. Candinas Kapitel 13 im „Facharztexamen Chirurgie“, EMH Schweizerischer Aerzteverlag 2009.

14. Fasziendehizenz und enterokutane Fisteln: Eine multidisziplinäre Herausforderung C. Kim, D. Inderbitzin, D. Candinas Zeitschrift für Wundheilung 2010, No. A, 35-38.

15. Unterschiedliche Kulturen – eine Plattform.

Viszerale Chirurgie und Medizin bilden im Inselspital erfolgreich eine interdisziplinäre Plattform Daniel Inderbitzin, Daniel Candinas Swiss Knife 2010, 3, 19-20.

16. Adhäsionen und Bauchschmerzen.

Peter Studer, Maria Mennicke, Daniel Inderbitzin Therapeutische Umschau 2011, 68 (8), 11.1.-11.5.

17. Checkliste Chirurgie F. Largiadèr, H.D. Saeger, M.J.B Keel, (Hsg.) D. Inderbitzin 10. Auflage 2012

18. Colon cancer cells produce immunoregulatory glucocorticoids.

D. Sidler, P. Renzulli, C. Schnoz, B. Berger, S. Schneider-Jakob, C. Flück, D. Inderbitzin, N. Corazza, D. Candinas, T. Brunner Oncoimmunology 2012, 1(4) 529-530.

19. Improving surgical outcome: combine evidence from unimodal interventions.

Response. V. Banz, D. Inderbitzin, S. Jakob Anesth Analg 2012;114(1): 241-242.

20. Aktuelles aus der Kolonchirurgie: Das kolo-rektale Karzinom

D. Inderbitzin Aerztemagazin Inselspital 2013; 24:38-40.

21. Changes in indications for surgery in the management of diverticulitis.

Galli R, Schnüriger B, Brügger L, Inderbitzin D. Ther Umsch. 2014;71(12):727-36.

16

22. Darmzentrum Tiefenau: Zum Wohl der Patienten M. Studer, D. Inderbitzin Medizin aktuell, Oktober 2014, Ausgabe Bern

23. Aktionsplan Gleichstellung: Chancengleichheit

Interview: Dr. R. Cecini, Dr. A. Ringger, Prof. D. Inderbitzin, Universität Bern 2014

24. Changes in indications for surgery in the management of diverticulitis. Galli R, Schnüriger B., Brügger L, Inderbitzin D. Ther Umsch. 2014; 71(12):727-36

25. Checkliste Chirurgie

F. Largiadèr, H.D. Saeger, M.J.B Keel, (Hsg.) D. Inderbitzin 110. Auflage 2017

Abstracts, Presentations 1. P 2. May 28th -30th, Basel 3. Validation of the E-PASS scoring system for the prediction of mortality and morbidity in

patients necessitating hepatic surgery. V. Banz, P. Studer, R. Fankhauser, D. Inderbitzin, D. Candinas SGC 2008, May 28th-30th, Basel

4. Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of

immediate outcome after pancreatic surgery: the score needs to be adapted. S. Deyle, M. Wagner, K. Becker, D. Inderbitzin, B. Gloor, D. Candinas SGC 2008, May 28th-30th, Basel

5. Do different preoperative chemotherapy regimens lead to distinct complication rates

after hepatic resection for colorectal liver metastases? P. Studer, L. Wilkens, V. Banz, D. Candinas, D. Inderbitzin SGC 2008, May 28th-30th, Basel

6. Patients necessitating hepatic resection for malignant or benign diseases have a

similar long-term quality of life. V. Banz, R. Fankhauser, P. Studer, D. Inderbitzin, D. Candinas SGC 2008, May 28th-30th, Basel

7. Control of pelvic sepsis with preservation of intestinal continuity in rectal anastomotic

dehiscence: a new treatment modality using subathmospheric pressure and intraluminal skin graft. Y. Borbély, D. Inderbitzin, C. Jost, D. Candinas, C. Seiler SGC 2008, May 28th-30th, Basel

8. Does the „Estimation of Physiologic Ability and Surgical Stress“ (E-PASS)-Score

enable surgeons to predict patients with bad outcome following esophageal resection for cancer? R. Kam, M. Wagner, G. Krämer, D. Inderbitzin, C. Seiler, D. Candinas SGC 2008, May 28th-30th, Basel

9. Inferior epigastric artery for revascularisation of a small accessory renal artery in kidney transplantation

17

U. Herden, S.W. Schmid, D. Inderbitzin, C.A. Seiler, D. Candinas SGC 2008, May 28th-30th, Basel

10. Fulminant liver failure due to sulfasalazine-induced DRESS syndrome: fatal recurrence

after liver transplantation. M. Mennicke, F. Stickel, L. Wilkens, D. Inderbitzin, W. J. Pichler, D. Candinas SGVC 2008, August 28th-29th, Interlaken

11. Extra-adrenal glucocorticoid synthesis in colorectal cancer and it’s role in tumor

immune evasion. D. Sidler, P. Renzulli, S. Jakob, M. Noti, C. Schnoz, N. Corazzo, B. Berger, D. Inderbitzin,Candinas, T. Brunner DKF-Tag 2008, November 5th Bern (Poster Presentation)

12. Influence of granulocyte-colony simulating factor (G-CSF) on tumorigenicity of

colorectal carcinoma. Y. Borbély, N. Graubarth, S. Vorburger, G. Beldi, A. Keogh, D. Stroka, D. Candinas, D. Inderbitzin DKF-Tag 2008, November 5th Bern (Poster Presentation)

13. Soft tissue navigation: Transferring pre-operative planning data into the operation room

M. Peterhans, B. Dagon, L.-P. Nolte, C. Baur, A. Vom Berg, D. Inderbitzin, S. Weber ECR 2009, March 6th -10th, Vienna

14. A porcine liver model for validation of registration accuracy in image-guided surgery.

M. PeterhanS, B. Dagon, A. Vom Berg, S. Ross, D. Inderbitzin, C. Baur, S. Weber BVM 2009, March 23rd, Heidelberg

15. Influence of granulocyte-colony stimulating Factor (G-CSF) on the tumorigenicity of

colorectal carcinoma. Y. Borbely, N. Graubardt, S. Vorburger, G. Beldi, A. Keogh, D. Stroka, D. Candinas, D. Inderbitzin SGC 2009, June 10th-12th, Montreux, Switzerland.

16. Acute liver failure due to amanita phalloides poisoning. Is ICG-PDR a helpful tool in

decision making and what criteria can be applied for emergency liver transplantation? J.-M. Gass, M. Wagner, D. Inderbitzin, J.-F. Dufour, D. Candinas, SGC 2009, June 10th-12th, Montreux, Switzerland.

17. A20 is central to liver regeneration: Delayed regeneration and increased inflammation

in A20 heterozygote mice. P. Studer, C. da Silva, M. Skroch, J. J. Siracuse, S. M. Damrauer, D. Inderbitzin, E. Kaczmarek, D. Candinas, D. Stroka, C. Ferran SGC 2009, June 10th-12th, Montreux, Switzerland.

18. A20 Promotes Hepatocyte Proliferation by Enhancing IL-6 Signaling.

P. Studer, C. da Silva, M. Skroch, S. M. Damrauer, J. J. Siracuse, E. Maccariello, D. Inderbitzin, E. Kaczmarek, D. Candinas, C. Ferran SGC 2009, June 10th-12th, Montreux, Switzerland.

19. Soft tissue navigation: An ex-vivo porcine liver model for multimodality imaging and

simulation of deformations to validate techniques for image-guided liver surgery. A. vom Berg, M. Peterhans, B. Dagon, L. P. Nolte, C. Baur, S. Weber, D. Inderbitzin, D. Candinas SGC 2009, June 10th-12th, Montreux, Switzerland.

18

20. Laparoscopic transgastric pancreatic necrosectomy and pseudocysto-gastrostomy in severe acute pancreatitis: First results of a new technique. C. Kim, C. Stathakis, E. Angst, A. Kurmann, A. Lechleiter, D. Inderbitzin, B. Gloor, D. Candinas SGVC 2009, September 17th-18th, Zürich, Switzerland (Oral).

21. Advanced age increases the failure rate of non-operative management of blunt splenic

injuries. P. Renzulli, B. Schnüriger, T. Gross, D. Inderbitzin, D. Candinas SGVC 2009, September 17th-18th, Zürich, Switzerland (Poster).

22. Soft tissue navigation: An ex-vivo porcine liver model for multimodality imaging and

simulation of deformations to validate techniques for image-guided liver surgery. A. vom Berg, M. Peterhans, B. Dagon, L. P. Nolte, C. Baur, S. Weber, D. Inderbitzin, D. Candinas SGVC 2009, September 17th-18th, Zürich, Switzerland (Oral).

23. Fasziendehizenz und enterokutane Fisteln: Eine multidisziplinäre Herausforderung

C. Kim, D. Inderbitzin, D. Candinas Dreiländerkongress 2010, April 16th-17th, Zürich, Switzerland (Oral).

24. The new Swiss transplant law leads to an increased disparity between donor

recruitment and transplant activity, prolonged waiting time and increased mortality on the waiting list on a single liver transplant center: time for a change. P. C. Nett, S. W. Schmid, D. Inderbitzin, J. Reichen, J. F. Dufour, C. A. Seiler, D. Candinas SGC 2010, May 26th-28th, Interlaken, Switzerland (Oral).

25. Integration of computer assisted surgery and intraoperative navigation in complex liver

surgery and tumor ablation: First results after treatment of 10 patients. A. vom Berg, D. Inderbitzin, M. Peterhans, L. Nolte, S. Weber, D. Candinas. SGC 2010, May 26th-28th, Interlaken, Switzerland (Oral).

26. The protective effect of A20 against severe liver ischemia reperfusion injury is

abolished in PPARalpha-null mice. P. Studer, C. da Silva, E. Csizmadia, S. Damrauer, C. Peterson, D. Inderbitzin, D. Stroka, D. Candinas, C. Ferran. SGC 2010, May 26th-28th, Interlaken, Switzerland (Oral).

27. Age over 40 years increases the failure rate of non-operative management of blunt

splenic injuries. P. Renzulli, T. Gross, B. Schnüriger, A. M. Schoepfer, D. Inderbitzin, A. K. Exadaktylos, H. Hoppe, D. Candinas SGC 2010, May 26th-28th, Interlaken, Switzerland (Oral).

28. Gene chip analysis of A20 expressing livers following extended liver resections

uncovers its multiple targets that promote liver repair and regeneration. P. Studer, C. da Silva, C. Longo, M. Bhasin, T. Libermann, D. Inderbitzin, D. Candinas, D. Stroka, C. Ferran. SGC 2010, May 26th-28th, Interlaken, Switzerland (Poster).

29. Clinical outcome of instrument guided microwave ablation during liver surgery.

M. Peterhans, N. Reynolds, D. Inderbitzin, A. vom Berg, J. Kettenbach, L. Nolte, D. Candinas, S. Weber SMIT 2010, September 2nd-4th, Trondheim, Norway

19

30. Instrument-guided microwave ablation of liver tumor during liver surgery. D. Inderbitzin, M. Peterhans, N. Reynolds, A. vom Berg, J. Kettenbach, L. Nolte, D. Candinas, S. Weber SMIT 2010, September 2nd-4th, Trondheim, Norway

31. Partial liver resection reveals a distinct phenotype in A20 heterozygote mice.

P. Studer, C. da Silva, E. Csizmadia, M. Mennicke, D. Inderbitzin, D. Stroka, D. Candinas, C. Ferran SGC 2011, May 25th-27th, Genf, Switzerland

32. How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic

cancer? E. Angst, C. Kim-Fuchs, Y. Chittazhattu Kurian Kuruvilla, D. Inderbitzin, M. Montoni, D. Candinas, B. Gloor SGC 2011, May 25th-27th, Genf, Switzerland

33. Metastatic neuroendocrine tumors and liver metastasis. How much surgery is

applicable? C. Kim-Fuchs, E. Angst, D. Inderbitzin, C. Seiler, B. Gloor, D. Candinas SGC 2011, May 25th-27th, Genf, Switzerland

34. Laparoscopic terminal colostomy closure: hope of hype?

M. Umer, B. Schnüriger, D. Kröll, U. Güller, D. Inderbitzin, D. Candinas SGC 2011, May 25th-27th, Genf, Switzerland

35. Management of splenic artery aneurysms

C. Kim-Fuchs, E. Angst, D. Inderbitzin, B. Gloor, D. Candinas SGC 2011, May 25th-27th, Genf, Switzerland

36. Metastatic neuroendocrine tumors and liver metastasis. How much surgery is

applicable? C. Kim-Fuchs, E. Angst, D. Inderbitzin, C. Seiler, B. Gloor, D. Candinas SGG-SGVC 2011, September 29th-30th, Lausanne, Switzerland

37. Management of splenic artery aneurysms

C. Kim-Fuchs, E. Angst, K. Breu, D. Inderbitzin, B. Gloor, D. Candinas SGG-SGVC 2011, September 29th-30th, Lausanne, Switzerland

38. Comparison of predicted versus effective microwave ablation volumes in an ex-vivo

porcine liver model. P. Müller, V. Banz, D. Inderbitzin, M. Peterhans, D. Candinas, S. Weber IHPBA 2012, July 1st-5th, Paris, France.

39. Evaluation of predicted versus effective ablation volumes in an ex-vivo procine liver

model. P. Müller, D. Inderbitzin, M. Peterhans, S. Weber, D. Candinas, V. Banz 99th SGC 2012, June 20th-22nd, Davos, Switzerland.

40. Intratumoral budding is preoperative biopsies predicts local and distant metastasis in

colorectal cancer patients. A. Lugli, M. Haedrich, D. Inderbitzin, M. Borner, I. Zlobec 24th European Congress of Pathology 2012, September 8th to 12th, Prague, Czech Republic. (Oral presentation)

41. Prognostic impact of lymph node ratio outperforms positive lymph nodes and lymph nodes harvested: a time-dependent analysis in mismatch repair-proficient and –deficient colrectal cancers.

20

I. Zlobec, E. Karamitopoulou, L. Terracciano, D. Inderbitzin, A. Lugli 24th European Congress of Pathology 2012, September 8th to 12th, Prague, Czech Republic. (Poster presentation)

42. Cdx2 loss is a frequent indicator of high-level microsatellite instability (MSI-H) status in

colorectal cancer. H. Dawson, V. Koelzer, D. Inderbitzin, A. Lugli, I. Zlobec Tag der Klinischen Forschung 2012, November 14th, Bern, Switzerland. (Poster presentation)

43. Intratumoral budding (ITB) in pre-operative biopsies: a strong indicator of lymph node

positivity in colon and rectal cancer patients. H. Dawson, M. Haedrich, V. H. Koelzer, D. Inderbitzin, M. Borner, I. Zlobec, A. Lugli USCAP 2013, July 14th to 19th, Anchorage, Alaska. (Poster presentation)

44. The CD8/CD45RO immunoscore in biopsy specimens of colorectal cancer predicts

histopathologic features of the matched resection specimen and survival outcome. V. H. Koelzer, D. Inderbitzin, M. Borner, I. Zlobec, A. Lugli AACR 2013, (Poster presentation)

45. Incision length for kidney transplantation does not influence short or long-term

outcome: a prospec- tive randomized controlled trial. T. Malinka, V. Banz, D. Inderbitzin, D. Candinas 100th SGC 2013, June 12th -14th, Bern, Switzerland. (Oral presentation)

46. Intratumoral budding (ITB) in pre-operative biopsies: a strong indicator of lymph node

positivity in colon and rectal cancer patients. H. Dawson, M. Haedrich, M. Borner, I. Zlobec, A. Lugli, D. Inderbitzin 100th SGC 2013, June 12th -14th, Bern, Switzerland. (Poster Presentation)

47. Indications for stereotactic liver surgery: findings from a single center study over 4

years V. Banz Wüthrich, P. Tinguely, M. Worni, P. Müller, D. Inderbitzin, D. Ribes, M. Peterhans, S. Weber, D. Candinas, SGC 2014, May 21st-23rd Bern, Switzerland.

48. A multicentre inter-observer study on tumour budding using a 10HPF method in

colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP). Viktor H. Koelzer, Inti Zlobec, Gieri Cathomas, Klaus Dirschmid, Felix Offner, Giacomo Puppa, Luigi Tornillo, Martin D. Berger, Markus Borner, Heather Dawson, Marion Hädrich, Makhmudbek Mallaev, Beat Schnüriger, D. Inderbitzin, Alessandro Lugli, European Congress of Pathology 2014, Sept 1-4th, London, UK

49. Single center experience with stereotactiv liver surgery: A review over 5 years.

V. Banz, P. Tinguely, M. Worni, P. Müller, D. Inderbitzin, D. Ribes, M. Peterhans, S. Weber, D. Candinas, AASLD 2014, November 7th– 11th, Boston, USA

50. Tumor budding in colorectal cancer: a multicenter inter-observer study on behalf of the

Swiss Association of Gastrointestinal Pathology (SAGIP) . V.H. Koelzer, I. Zlobec, M. D. Berger, G. Cathomas, H. Dawson, K. Dirschmid, M. Hädrich, D. Inderbitzin, F. Offner, G. Puppa, W. Seelentag, B. Schnüriger, L. Tornillo, A. Lugli, Swiss Society of Pathology 2014, Nov 6th-8th, Lausanne, Switzerland.

51. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer. J. A. Galván, M. Helbling, V. H. Koelzer, M.P. Tschan, M.D. Berger,

21

M. Hädrich, B. Schnüriger, E. Karamitopoulou, H. Dawson, D. Inderbitzin, A. Lugli, I Zlobec, Swiss Society of Pathology 2014, Nov 6th-8th, Lausanne, Switzerland.

52. Tumor budding in colorectal cancer: a multicenter inter-observer study on behalf of the

Swiss Association of Gastrointestinal Pathology (SAGIP) . V.H. Koelzer, I. Zlobec, M. D. Berger, G. Cathomas, H. Dawson, K. Dirschmid, M. Hädrich, D. Inderbitzin, F. Offner, G. Puppa, W. Seelentag, B. Schnüriger, L. Tornillo, A. Lugli, USCAP 2015, March 21st-27th , Boston, USA

53. A TWIST to the tale: Effect of TWIST1 and TWIST2 promoter methylation and protein

expression in tumor stroma on the tumor budding phenotype in colorectal cancer. V. H. Koelzer, J. A. Galván, M. Helbling, M.P. Tschan, M.D. Berger, M. Hädrich, B. Schnüriger, E. Karamitopoulou, H. Dawson, D. Inderbitzin, A. Lugli, I Zlobec, USCAP 2015, March 21st-27th , Boston, USA

54. Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in

Pancreatic Cancer on MDCT K. Schawkat, W. Kühn, D. Inderbitzin, B. Gloor, JT. Heverhagen, VM Runge, A. Christe, PLoS One. 2016 Nov 28; 11(11):e0166003. doi: 10.1371/journal.pone.0166003. eCollection 2016

55. Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer VH. Koelzer, L. Sokol, S. Zahnd, L. Christe, H. Dawson, MD Berger, D. Inderbitzin, I. Zlobec, A. Lugli, Oncoimmunology. 2017 Feb 6; 6/4):e1288330. doi: 10.1080//2162402X.2017.1288330. eCollection 2017

56. Genetic variation within the PD-L2 immune checkpoint gene are associated with

outcome in stage II and III colon cancer Berger M, Zlobec I, Yang D, Cao S, Sunakawa Y, Matsusaka S, Koelzer V, Inderbitzin D, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Soni S, Puccini A, Tokunaga R, Naseem M, Zhang W, Lugli A, Lenz H-J

Invited Lectures 1. Bone marrow-derived hepatic stem cells.

D. Inderbitzin. Interdisciplinary weekly research conference, April 2001, University of Zurich Hospital, Zurich, Switzerland.

2. Isolation and characterisation of bone marrow derived hepatic stem cells.

D. Inderbitzin, I. Avital. Meeting of the European Liver Cell Network, October 23rd 2001, Padua, Italy.

3. Hepatocyte Specific Metabolic Activity of Bone Marrow Derived Hepatic Stem Cells

Under Different Culture Conditions D. Inderbitzin, I. Avital. Meeting of the European Liver Cell Network, October 23rd 2001, Padua, Italy.

4. Syngeneic liver stem cell transplantation in allogeneic liver graft.

C. Ferraresso, D. Inderbitzin, I. Avital. Meeting of the European Liver Cell Network, October 23rd 2001, Padua, Italy.

5. Bone marrow-derived liver stem cells.

D. Inderbitzin. Interdisciplinary meeting of the liver unit, December 2002, Birmingham, GB.

22

6. Isolation and characterization of bone marrow-derived hepatic stem cells.

I. Avital, D. Inderbitzin. Annual Meeting of the European Liver Cell Network. May 24th 2002, Padua, Italy.

7. Hepatocyte specific metabolic activity of bone marrow derived hepatic stem cells.

D. Inderbitzin, I. Avital. Annual Meeting of the European Liver Cell Network. May 24th 2002, Padua, Italy.

8. Adult bone marrow derived liver stem cells.

D. Inderbitzin. Interdisciplinary Transplantation Meeting, July 8th 2002, University of Zurich Hospital, Zurich, Switzerland.

9. The Blunt Tip Needle

D. Inderbitzin Seminar Johnson & Johnson, Spreitenbach, March 11th 2003.

10. Poster Session: Surgical pathophysiology, tissue repair, wound healing

Chair: D. Inderbitzin, M. Boros ESSR 2003, May 30th 2003, Ghent, Belgium

11. Hepatobiliary and pancreatic session IChair: D. Inderbitzin, H. Waclawicek ESSR 2003, May 30th 2003, Ghent, Belgium

12. Adult Liver Stem Cells

D. Inderbitzin Seminar at the Department for Clinical Research University of Bern, June 4th 2003.

13. Stammzellen in der Chirurgie

D. Inderbitzin Research Meeting HGEK Inselspital Bern, June 16th 2003

14. Member of the European communications advisory board for surgical site infections

and Vicryl-Plus. D. Inderbitzin Euro RSCG Life NRP, August 28th/29th 2004, Vienna

15. Wound management

D. Inderbitzin Aeskulap Academy, Kantonsspital Aarau, December 26th 2004

16. Biological principles of wound healing.

D. Inderbitzin University of Bern, April 22nd 2004

17. The anatomy of the biliary tree from a surgical point of view.

D. Inderbitzin Gastroenterological Seminar, University of Bern, April 27th 2004

18. Poster session: Visceral surgery (Clinical)

Chair: D. Inderbitzin, H. Baer SGC 2004, June 25th, Davos

19. Invited comment: Different etiology of steatosis has different tolerance to ischemic-

reperfusion injury.

23

D. Inderbitzin SGC 2004, June 25th, Davos

20. Invited comment: Platelets: A novel pathway of liver regeneration.

D. Inderbitzin SGC 2004, June 25th, Davos

21. Clinical session: Visceral Surgery

Chair: D. Inderbitzin, I. Langer SGC 2005, June 9th, Zurich

22. Invited comment: Human mesenchymal stem cells

D. Inderbitzin SGC 2005, June 10th, Zurich

23. Leberchirurgie D. Inderbitzin Nationale Weiterbildung Intensivpflegepersonal 2005, June 11th, Bern

24. Fokale Noduläre Hyperplasie

D. Inderbitzin Interdisziplinäre Viszeralchirurgie, September 1st, 2005 Inselspital Bern

25. Unterstützung der Leberregeneration durch Präkonditionierung adulter Stammzellen

D. Inderbitzin Vortrag DKF Forschungspreis 2004, September 14th, 2005, Universität Bern

26. Wundheilung, Wundinfekt und Prophylaxe – nur graue Theorie?

D. Inderbitzin 16. Berner Chirurgie-Symposium, November 4th, 2005 Inselspital Bern.

27. Invited comment: Xenotransplantation induces chimerism in rats

D. Inderbitzin SGC 2006, June 23rd, Lugano

28. Invited comment: Long-term effects of islet transplantation on liver parenchyma

D. Inderbitzin SGC 2006, June 23rd, Lugano

29. Die weltweit erste ABO inkompatible auxiliäre orthotope Lebertransplantation!

D. Inderbitzin. Interdisziplinäre Fallvorstellung des Inselspitals (IFI): June 28th 2006, Inselspital Bern.

30. External liver support: much ado about nothing?

D. Inderbitzin. 28. Berner Anästhesie-Symposium, September 6th 2006, Inselspital Bern.

31. What I would do differently in the next project?

D. Inderbitzin 3 rd Experimental Surgery Symposium 2007, January 19th 2007, Universitätsspital Bern, Bern, Switzerland.

32. Invited comment: Potential of hepatocyte differentiation for human mesenchymal stem

cells is age dependent. D. Inderbitzin SGC 2007, June 13th, Lausanne

24

33. PhD in applied physiology (Autumn course 2007)

Isolation of putative liver stem cells – link to liver regeneration? D. Inderbitzin Universitätsspital Bern, Dezember 11th 2007

34. Intraoperative cholangiography: Always? No, only in selected cases.

D. Inderbitzin SGC 2008, May 28, Basel

35. Liver incidentalomas: the case against surgery.

D. Inderbitzin SGVC 2008, August 28th-29th, Interlaken

36. Experimental settings in research of the liver

Chair: D. Inderbitzin 5 th Swiss Experimental Surgery Symposium 2009, January 22nd/23rd 2009, University of Fribourg, Fribourg, Switzerland.

37. Animal-models of acute and chronic liver injury

D. Inderbitzin 5 th Swiss Experimental Surgery Symposium 2009, January 22nd/23rd 2009, University of Fribourg, Fribourg, Switzerland.

38. Invited comment: Spontaneous GM-CSF secretion from tumor cells plays a critical role

in anti-tumor immunity D. Inderbitzin SGC 2009, June 10th, Montreux

39. Visceral Surgery: Novel Technologies

Chair: D. Inderbitzin, F. Pugin SGC 2009, June 12th, Montreux

40. Chirurgischer Pflegekongress Aarau. Der Gastrointestinaltrakt: Mögliche postoperative

Komplikationen; Reagieren – Agieren (mit interaktiver Falldemonstration) D. Inderbitzin October 29th 2009, Aarau

41. Chirurgie und Risiko: Eine Analyse

D. Inderbitzin MIC 2010, Asklepios Kliniken Langen March 5th 2010, Königstein im Taunus, Germany

42. Interdisziplinäre Viszerale Chirurgie und Medizin:

Der grosse Tumor: Operation oder doch nicht? D. Inderbitzin May 6th 2010, Universitätsspital Bern, Inselspital

43. Chair of the Main Visceral Session: Anastomosis in visceral surgery

D. Inderbitzin SGC 2010, May 26th, Interlaken, Switzerland.

44. Chirurgischer Pflegekongress Aarau Hernien, Leisten- und Narbenbrüche, (mit interaktiver Falldemonstration) D. Inderbitzin October 28th 2010, Aarau

25

45. Workshop Organtransplantation Universitätsklinik für Viszerale Chirurgie und Medizin

D. Inderbitzin Transplantationsverfahren, Gesetzgebung, Ethik March 29th, June 6th 2011, Inselspital Bern

46. Chair of the hepato-pancreatico-biliary and transplantation session II D. Inderbitzin SGC 2011, May 25th, Genf, Switzerland

47. Chirurgischer Pflegekongress Aarau

D. Inderbitzin Palliative Viszeralchirurgie October 27th, 2011, Aarau

48. Berner Chirurgie Symposium 2011

D. Inderbitzin Pitfalls in Rektum-Chirurgie November 4th, 2011, Bern Inselspital, Switzerland

49. Fortbildung Transplantation

D. Inderbitzin February 1st, 2012, Spitäler FMI, Interlaken, Switzerland

50. Chair of the Visceral Session

D. Inderbitzin ESTES 2012, Basel, May 12th – 15th

51. The role of laparotomy in the acute abdomen

D. Inderbitzin, D. Candinas ESTES 2012, Basel, May 14th

52. Risiko-Abwägung in der Chirurgie

D. Inderbitzin June 4th 2012, Spitäler FMI, Interlaken, Switzerland

53. Chirurgie und Risiko: Die Perspektive des Chirurgen

D. Inderbitzin January 9th 2013, University Hospital Bern, Bern, Switzerland

54. Chair of the Transplantation Session (SGVC)

D. Inderbitzin SGC 2013, June 12th, Bern, Switzerland

55. Interdisziplinäre Viszeralchirurgie: Kolorektale Chirurgie

D. Inderbitzin August 15th 2013, Bern, Switzerland

56. Mittelländisches Chirurgenforum: Case presentations

D. Inderbitzin January 15th 2014, Langenthal, Switzerland

57. Workshop: „Das akute Abdomen“

D. Inderbitzin Hausärzte-Tag Bern 2014, March 13th, Inselspital, Switzerland

26

58. Chirurgischer Pflegekongress Aarau: Komplikationen in der Viszeralchirurgie D. Inderbitzin May 12th, 2014, Aarau, Switzerland

59. Medizinvorträge „medizinaktuell“: Das Kolonkarzinom

D. Inderbitzin February 24th 2014, Tiefenau, Switzerland

60. Chair of the Session and Interactive Case Presentation: Abdominal Surgery

D. Inderbitzin SGG 2014, September 12th, Interlaken, Switzerland

61. Q-Circle (Aerztenetzwerk Grauholz): Modern colorectal surgery

D. Inderbitzin November 5th 2014, Bern, Switzerland

62. GEF-Direktion Bern: Chancen und Risiken des abgestuften Versorgungsmodells am

Beispiel des Tiefenauspitals. D. Inderbitzin November 11th, 2014, Tiefenau, Switzerland

63. Diverticular disease

D. Inderbitzin BETAKLI 2014, November 12th, Bern, Switzerland

64. Q-Circle (Aerztenetzwerk Länggasse): Diverticular disease, hemorrhoidal disease

(HAL/RAR). D. Inderbitzin March 2nd 2015, Bern, Switzerland

65. Q-Circle (Qualitätszirkel Weissenstein): Perspektiven und Zusammenarbeit, D. Inderbitzin April 26th 2016, Rüttenen, Switzerland

66. Interdisziplinäre Ärztliche Fortbildung: Update Viszeralchirurgie D. Inderbitzin May 12th 2016, Solothurn, Switzerland

67. Interdisziplinäre Ärztliche Fortbildung, Schluckstörung: Viszeralchirurgische Krankheitsbilder D. Inderbitzin June 9th 2016, Solothurn, Switzerland

68. Chirurgie Bürgerspital Solothurn, Chirurgie soH GAeSO Gesellschaft der Ärztinnen und Ärzte des Kantons Solothurn D. Inderbitzin June 16th 2016, Solothurn, Switzerland

69. Q-Circle (Qualitätszirkel Inneres Wasseramt): Update Divertikulitis D. Inderbitzin October 25th 2016, Kriegstetten, Switzerland

70. Berner Chirurgie Symposium 2016 D. Inderbitzin Die Blut-Gerinnung, eine Chirurgische Hassliebe in mehreren Akten November 4th, 2016, Bern Inselspital, Switzerland

27

71. MEDIfuture D. Inderbitzin November 5th, 2016, Bern Stade de Suisse, Switzerland

72. Q-Circle (Qualitätszirkel Weststadt): Chirurgie BSS 2017

D. Inderbitzin February 27th 2017, Solothurn, Switzerland

73. Q-Circle (Qualitätszirkel Weissenstein): Update Divertikulitis 2017 D. Inderbitzin March 7th 2017, Rüttenen, Switzerland

74. Q-Circle (Qualitätszirkel Thal): Chirurgie soH 2017 D. Inderbitzin August 21st 2017, Balsthal, Switzerland

75. Q-Circle (Qualitätszirkel Grenchen): Chirurgie Solothurn 2017 D. Inderbitzin August 30th 2017, Grenchen, Switzerland

76. 19th Alpine Colorectal Meeting Wengen

D. Inderbitzin January 28th to January 30th

Teaching Activities at the Faculty of Medicine, University of Berne 1. Die chirurgische Behandlung der Echinococcose: 02.06.2003

2. Fieber in der Chirurgie: 31.10.2005

3. Akutes Abdomen: 19.10.2009

4. Masterstudiengang Biomedical Sciences: Liver Regeneration and Stem Cells: 12.02.2010

5. OP-Techniken. Grundsätze der Asepsis. Verhalten im OP. Wie lerne ich Chirurgie? 01.11.2010

6. Die Wunde: 01.11.2010

7. Schock und Trauma: 01.11.2010

8. Akutes Abdomen: 19.10.2009; 04.11.2010

9. Clinical Skills, Abdomen, (4th year, 10x): 2002, 2013, 2014, 2015, 2017

10. Problem-based learning: 26.04.2004; 29.04.2004; 03.05.2004; 06.05.2004; 10.05.2004; 13.05.2004; 17.05.2004; 24.05.2004; 27.05.2004; 03.06.2004; 07.06.2004; 10.06.2004; 14.06.2004; 17.06.2004; 21.06.2004; 24.06.2004

11. The laparoscopic appendicectomy: 02.06.2005.

12. Surgery of the esophagus: 03.06.2002; 04.11.2002; 02.06.2003; 14.03.2003; 29.09.2003; 15.02.2004; 230.8.2004; 24.01.2005; 19.12.2005; 29.05.2006; 18.07.2006; 06.11.2006; 23.04.2007, 23.05.2008, 16.12.2008; 18.03.2010; 08.04.2011;

13. Appendicitis acuta: 12.01.2004; 21.06.2004; 29.11.2004; 17.10.2005; 09.05.2005; 27.02.2006; 11.09.2006; 05.03.2007.

28

14. Closing the incision: 11.01.2005

15. Basics and Politics in Stem Cells: 22.03.2005

16. The artificial liver: MARS: 16.08.2004

17. Anaesthesia and visceral surgery: 22.10.2007, 21.04.2008, 09.02.2009, 20.10.2009, 21.06.2010, 06.12.2010, 01.11.2011

18. Aesculap Academy (Member of the scientific committee): Sutures Training Center. Instructor for basic courses: 27.04.2004; 16.11.2004; 02.05.2005; 21.06.2005; 08.11.2005; 15.05.2006; 11.12.2006; 14.05.2007; 10.12.2007; 09.12.2008; 26.05.2009; 15.12.2009; 14.12.2010; 17.05.2011; 27.03.2012; 14.05.2013; 21.04.2015; 15.03.2016;

19. Kolonchirurgie (VIS 5, 4.SJ): 31.10.2011, 04.11.2011; 09.11.2012, 08.11.2013; 07.11.2014; 06.11.2015; 04.11.2016; 07.11.2017

20. Repetitorium (6.SJ): 08.04.2013, 02.05.2013, 08.11.2013, 19.03.2014, 18.03.2015;

21. Studienjahr 4 EKP VIS6 Kolon Operative Strategien (1 Std): 07.11.2017

22. Studienjahr 4 EKP GAS3 Kolonkarzinom (1 Std): 07.11.2017

Student promotion at the Faculty of Medicine, University of Berne 1. M. Gass

Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver. Submitted to the Faculty of Medicine, University of Bern: 27.08.2004; Dissertation accepted: 19.10.2004.

2. P. Studer:

Regenerative capacity of remnant liver lobes after partial hepatectomy in the mouse Submitted to the Faculty of Medicine, University of Bern: 29.03.2006; Dissertation accepted: 05.07.2006.

3. D. Sidler

Granulocyte-colony stimulating factor increases hepatic sinusoidal perfusion during liver regeneration in mice. Submitted to the Faculty of Medicine, University of Bern: 19.12.2007; Dissertation accepted: 12.03.2008.

4. M. Schafer

Management of High-Grade Blunt Hepatic Trauma: Clinical Complications and the Role of Concomitant Injuries Submitted to the Faculty of Medicine, University of Bern: 05.11.2008; Dissertation accepted: 01.04.2009.

5. R. T. Fankhauser

Long-term quality of life after hepatic resection: Health is not simply the absence of disease. Submitted to the Faculty of Medicine, University of Bern: 06.03.2009; Dissertation accepted 08.07.2009.

6. B. Muggli

Molecular absorbent recirculating system for the treatment of acute liver failure after major liver resections and before and after orthotopic liver transplantation

29

Submitted to the Faculty of Medicine, University of Bern: 02.07.2009; Dissertation accepted: 7.10.2009.

7. T. Gross

Age over 40 increases the failure rate of non-operative management of blunt splenic injuries. Submitted to the Faculty of Medicine, University of Bern: 18.02.2010; Dissertation accepted: 07.04.2010.

8. T. Gross Traumatische Milzruptur. University of Bern, Master accepted: 13.09.2011.

9. S. Grundmann

Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells. Submitted to the Faculty of Medicine, University of Bern: 20.08.2015; Dissertation accepted: 16.09.2015

10. P. Müller

Intraoperative image-guided system: Development and applicability in 65 patients undergoing liver surgery. Submitted to the Faculty of Medicine, University of Bern Dissertation accepted: 20.04.2016

11. M. Hädrich (submitted) 12. A. Lukesch (submitted) 13. P. Träger 14. P. Moreno 15. G. Schmutz Awards 1. HLA expression in human neuronal progenitor cells: characterization and a novel

approach to isolation of specific neuronal stem cell subpopulations for transplantation. P. Kabos, I. Avital, A. Kabosova, S. Alshaeba, T. Salin-Nordstrom, D. Inderbitzin, N. Saad, Q. Wang, D. Tyan, W. Arnaout, T. Neuman MHC Conference University of Wisconsin. May 2000. Award: Best MHC conference abstract 2000.

2. Entrapment of isolated rat hepatocytes by SIO2 sol-gel: a novel encapsulation

technique. D. Inderbitzin, M. T. Vilei, S. Boninsegna, R. Dal Toso, N. Suggiyama, G. Carturan, A. A. Demetriou, M. Muraca, J. Rozga AASLD Dallas 51st Annual Meeting, October 2000 Hepatology 2000, Vol 32, No 4, 399A. Award: AASLD President’s Choice Poster 2000.

3. A subpopulation of bone marrow derived stem cells differentiates into a hepatocyte

lineage capable of ureagenesis in vitro. D. Inderbitzin, I. Avital, M. Sidler-Pfändler, P.Meier, B. Stieger AASLD Dallas 52nd Annual Meeting, October 2001, Hepatology 2001, Vol 34, No 4,

30

264A. Award: Research Workshop Travel Award 2001

4. Ischemia reperfusion injury is mitigated in transgenic, human C1 inhibitor

overexpressing mice. D. Inderbitzin, G. Beldi, D, Candinas ESSR 2003, Ghent 38th Congress, May 2003. Award: B. Braun Melsungen AG Poster Prize 2003 (1000 SFr.)

5. The effect of hematopoietic growth factors on survival in a novel surgical small for size

liver remnant mouse model. G. Beldi, A. Keogh, S. Bisch-Knaden, P. Studer, D. Stroka, D. Candinas, D. Inderbitzin SGC 2004, Davos 2nd Congress, June 2000 Award: SGC 2004: Johnson & Johnson Poster Prize (1000 SFr.)

6. The proliferative effect of Granulocyte-Colony stimulating factor (G-CSF) on

regenerating liver in vivo and on freshly isolated human hepatocytes in vitro. D. Inderbitzin Day of Clinical Research 2004, September 2004, University of Bern Award: DKF-Research Prize 2004 (Medical Faculty University of Bern, 30000 SFr.)

7. Mouse liver anatomy from a microsurgical point of view.

D. Sidler, P. Studer, G. Beldi, E. Ayuni, V. Djonov, D. Candinas, D. Inderbitzin Day of Clinical Research 2004, September 2004, University of Bern Award: Student Research Award 2004 (Medical Faculty, University of Bern: 2000 SFr.)

8. Interleukin-3 induces hepatocyte specific metabolic activity in cultured progenitor cells

from adult rat bone marrow. D. Inderbitzin, A. Keogh, G. Beldi, M. Gass, P. Studer, D. Stroka, B. Gloor, D. Candinas. SGGH 2004, September 9th-11th, Montreux. Award: SGGH 2004: Poster Prize

9. Regenerative capacity of individual liver lobes in the microsurgical mouse model.

P. Studer, D. Sidler, B. Gloor, D. Candinas, D. Inderbitzin, Award: Faculty Prize 2007 for MD Thesis (Medical Faculty, University of Bern: 500 SFr.).

10. The accuracy of FAST in 226 multiple injured patients with spleen and liver injury. B. Schnüriger, J. Kilz, D. Inderbitzin, M. Schafer, R. Kickuth, M. Luginbühl, H. Zimmermann, A. Exadaktylos, D. Candinas Award: SGGH 2007: Poster Prize

11. Soft tissue navigation: An ex-vivo porcine liver model for multimodality imaging and

simulation of deformations to validate techniques for image-guided liver surgery.

A. vom Berg, M. Peterhans, B. Dagon, L. P. Nolte, C. Baur, S. Weber, D. Inderbitzin,

D. Candinas

Award: SGVC 2009 “Felix Largiadèr”- Prize (2500 SFr.): Best Presentation

12. Entwicklung und Anwendung einer Navigations-Plattform für die Computer-assistierte

Leberchirurgie.

M. Peterhans, A. vom Berg, D. Inderbitzin, D. Candinas, S. Weber,

Award: Ypsomed Innovationspreis 2009 (25000 SFr)

31

13. Intratumoral budding (ITB) in pre-operative biopsies: a strong indicator of lymph node positivity in colon and rectal cancer patients. H. Dawson, M. Haedrich, M. Borner, I. Zlobec, A. Lugli, D. Inderbitzin Award: SGC Poster Prize 2013 (1250 SFr).

14. A TWIST to the tale: Effect of TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma on the tumor budding phenotype in colorectal cancer V. H. Koelzer, J. A. Galván, M. Helbling, M.P. Tschan, M.D. Berger, M. Hädrich, B. Schnüriger, E. Karamitopoulou, H. Dawson, D. Inderbitzin, A. Lugli, I Zlobec United States and Canadian Academy of Pathology Award: (USCAP2015) Stowell Orbison Award for best poster presentation

Patent Method for the isolation of stem cells by immunolabelling with HLA/MHC gene product marker D. Inderbitzin, I. Avital, W. Arnaout. US Patent: 6828145, European and Asian Patent: 02736685.5-2405-US0214499